10 Charts, 1 Growth Story: Join us for an Exclusive Webinar LIVE on April 23rd @6pm
Here is the latest financial fact sheet of FDC. For more details, see the FDC quarterly results and FDC share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -0.0 |
No. of shares | m | 174.40 |
% ch week | % | 4.9 |
% ch 1-mth | % | 16.6 |
% ch 12-mth | % | 33.8 |
52 week H/L | Rs | 378.0/228.0 |
No. of Mths Year Ending |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
5-Yr Chart Click to enlarge
|
---|
FDC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 144 | 176 | 274 | 240 | 319 | |
Low | Rs | 79 | 116 | 145 | 166 | 164 | |
Sales per share (Unadj.) | Rs | 47.6 | 50.0 | 56.6 | 57.0 | 61.6 | |
Earnings per share (Unadj.) | Rs | 7.6 | 8.3 | 8.8 | 10.6 | 9.9 | |
Diluted earnings per share | Rs | 7.8 | 8.5 | 9.0 | 10.8 | 9.9 | |
Cash flow per share (Unadj.) | Rs | 9.0 | 10.5 | 10.7 | 12.5 | 12.0 | |
Dividends per share (Unadj.) | Rs | 2.25 | 2.25 | 2.25 | 2.25 | 0 | |
Adj. dividends per share | Rs | 2.29 | 2.29 | 2.29 | 2.29 | 0.00 | |
Dividend yield (eoy) | % | 2.0 | 1.5 | 1.1 | 1.1 | 0 | |
Book value per share (Unadj.) | Rs | 47.5 | 52.7 | 59.0 | 71.4 | 73.2 | |
Adj. book value per share | Rs | 48.5 | 53.7 | 60.2 | 72.8 | 73.2 | |
Shares outstanding (eoy) | m | 177.83 | 177.83 | 177.83 | 177.83 | 174.40 | |
Bonus/Rights/Conversions | BB | - | - | - | BB | ||
Price / Sales ratio | x | 2.3 | 2.9 | 3.7 | 3.6 | 3.9 | |
Avg P/E ratio | x | 14.6 | 17.5 | 23.8 | 19.1 | 24.3 | |
P/CF ratio (eoy) | x | 12.3 | 13.9 | 19.6 | 16.2 | 20.2 | |
Price / Book Value ratio | x | 2.3 | 2.8 | 3.5 | 2.8 | 3.3 | |
Dividend payout | % | 29.6 | 27.0 | 25.5 | 21.2 | 0 | |
Avg Mkt Cap | Rs m | 19,784 | 25,919 | 37,246 | 36,055 | 42,118 | |
No. of employees | `000 | NA | 4.9 | 5.3 | 5.3 | 5.5 | |
Total wages/salary | Rs m | 1,221 | 1,376 | 1,764 | 1,911 | 2,167 | |
Avg. sales/employee | Rs Th | NM | 1,803.9 | 1,907.0 | 1,899.3 | 1,943.7 | |
Avg. wages/employee | Rs Th | NM | 279.1 | 334.4 | 358.0 | 391.7 | |
Avg. net profit/employee | Rs Th | NM | 300.5 | 296.8 | 353.2 | 313.7 |
FDC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,459 | 8,893 | 10,063 | 10,139 | 10,751 | |
Other income | Rs m | 394 | 457 | 315 | 502 | 510 | |
Total revenues | Rs m | 8,852 | 9,350 | 10,379 | 10,641 | 11,260 | |
Gross profit | Rs m | 2,070 | 1,986 | 2,236 | 2,435 | 2,267 | |
Depreciation | Rs m | 249 | 388 | 337 | 346 | 351 | |
Interest | Rs m | 31 | 18 | 15 | 14 | 14 | |
Profit before tax | Rs m | 2,184 | 2,037 | 2,199 | 2,577 | 2,411 | |
Minority Interest | Rs m | 0 | 0 | 0 | 1 | -5 | |
Prior Period Items | Rs m | -225 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | -59 | 0 | |
Tax | Rs m | 606 | 555 | 633 | 633 | 671 | |
Profit after tax | Rs m | 1,353 | 1,481 | 1,566 | 1,885 | 1,735 | |
Gross profit margin | % | 24.5 | 22.3 | 22.2 | 24.0 | 21.1 | |
Effective tax rate | % | 27.7 | 27.3 | 28.8 | 24.6 | 27.8 | |
Net profit margin | % | 16.0 | 16.7 | 15.6 | 18.6 | 16.1 |
FDC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,355 | 5,021 | 4,954 | 7,083 | 7,213 | |
Current liabilities | Rs m | 1,792 | 1,880 | 1,638 | 1,793 | 2,104 | |
Net working cap to sales | % | 30.3 | 35.3 | 33.0 | 52.2 | 47.5 | |
Current ratio | x | 2.4 | 2.7 | 3.0 | 3.9 | 3.4 | |
Inventory Days | Days | 44 | 51 | 48 | 49 | 54 | |
Debtors Days | Days | 25 | 25 | 23 | 27 | 28 | |
Net fixed assets | Rs m | 3,025 | 3,930 | 6,752 | 6,844 | 6,865 | |
Share capital | Rs m | 179 | 179 | 179 | 179 | 175 | |
"Free" reserves | Rs m | 8,243 | 9,185 | 10,321 | 12,523 | 12,586 | |
Net worth | Rs m | 8,453 | 9,364 | 10,499 | 12,702 | 12,761 | |
Long term debt | Rs m | 11 | 9 | 8 | 7 | 6 | |
Total assets | Rs m | 10,557 | 11,487 | 12,337 | 14,679 | 15,041 | |
Interest coverage | x | 71.4 | 113.5 | 152.7 | 183.7 | 173.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | |
Return on assets | % | 13.1 | 13.1 | 12.8 | 12.9 | 11.6 | |
Return on equity | % | 16.0 | 15.8 | 14.9 | 14.8 | 13.6 | |
Return on capital | % | 23.5 | 21.9 | 21.1 | 19.9 | 19.0 | |
Exports to sales | % | 13.3 | 11.9 | 12.2 | 15.4 | 12.3 | |
Imports to sales | % | 3.3 | 3.9 | 3.7 | 0 | 0 | |
Exports (fob) | Rs m | 1,126 | 1,059 | 1,229 | 1,558 | 1,327 | |
Imports (cif) | Rs m | 283 | 345 | 372 | 0 | 0 | |
Fx inflow | Rs m | 1,146 | 1,066 | 1,398 | 2,118 | 1,889 | |
Fx outflow | Rs m | 355 | 411 | 434 | 0 | 0 | |
Net fx | Rs m | 791 | 655 | 964 | 2,118 | 1,889 |
FDC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,485 | 1,276 | 1,748 | 1,545 | 1,498 | |
From Investments | Rs m | -620 | -886 | -748 | -1,436 | 201 | |
From Financial Activity | Rs m | -753 | -478 | -967 | 4 | -1,694 | |
Net Cashflow | Rs m | 113 | -87 | 34 | 109 | 10 |
Share Holding
|
Company Information
|
CHM: M. A. Chandavarkar (MD) | COMP SEC: Varsharani Katre | YEAR OF INC: 1900 | BSE CODE: 531599 | FV (Rs): 1 | DIV YIELD (%): - |
Read: FDC LTD. 2017-18 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: NEULAND LABS J.B.CHEMICALS DIVIS LABORATORIES PIRAMAL ENTERPRISES IPCA LABS
Compare FDC With: NEULAND LABS J.B.CHEMICALS DIVIS LABORATORIES PIRAMAL ENTERPRISES IPCA LABS
Compare FDC With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.
For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video I tell you the three Nifty ETFs I think are the best.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More